This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Roche Diagnostics Corporation for a service agreement to provide Ventana Benchmark Ultra Immunostainers. The contract has a ceiling value of $15,649.32 and a period of performance ending on March 24, 2026. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does not have a set-aside designation. Roche Diagnostics has a history of providing critical medical equipment, reagents, and testing services to various federal agencies, including the Department of Veterans Affairs, Department of Defense, and Indian Health Service, through prime contracts, subcontracts, and Indefinite Delivery Vehicles such as Blanket Purchase Agreements and Indefinite Delivery Contracts.
Generated 11/27/24, 9:28 AM